Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

As recommended in the ECHA Guidance we have performed threein- vitro and in- chemico tests on skin sensitisation covering the key events of adverse outcome pathway (AOP):

 

1.)  Direct Peptide Reactivity Assay (DPRA)

In this guideline study under GLP conditions, the test item showed minimal reactivity towards bothpeptides.The test item is considered as non-sensitiser in the DPRA.

 

2.)  ARE-Nrf2 Luciferase Test Method (KeratinoSens™)

In this guideline study under GLP conditions, the test itemdid not induce the luciferase activity in the transgenic KeratinoSens™ cell line in at least two independent experiment runs. Therefore, the test item can be considered asnonsensitiser in the KeratinoSens™.

 

3.)  Human Cell Line Activation Test (h-CLAT)

In this guideline study under GLP conditions,the test item did upregulate the cell surface markers in at least two independent experiment runs. Therefore, the test item is considered to be a skin sensitiser in the h-CLAT in accordance with UN GHS category 1.

 

For details, please see study summary.

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Due to the AOP-based “two out of three” skin sensitization integrated testing strategy (ITS) for hazard identification we classify the substance as “non sensitiser” since the DRPA and KeratinoSens™ study were negative.